Cargando…
JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases
The c-Jun N-terminal kinase 3 (JNK3) is the JNK isoform mainly expressed in the brain. It is the most responsive to many stress stimuli in the central nervous system from ischemia to Aβ oligomers toxicity. JNK3 activity is spatial and temporal organized by its scaffold protein, in particular JIP-1 a...
Autores principales: | Musi, Clara Alice, Agrò, Graziella, Santarella, Francesco, Iervasi, Erika, Borsello, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600688/ https://www.ncbi.nlm.nih.gov/pubmed/32998477 http://dx.doi.org/10.3390/cells9102190 |
Ejemplares similares
-
Synaptic alterations as a common phase in neurological and neurodevelopmental diseases: JNK is a key mediator in synaptic changes
por: Musi, Clara Alice, et al.
Publicado: (2022) -
JNK signaling provides a novel therapeutic target for Rett syndrome
por: Musi, Clara Alice, et al.
Publicado: (2021) -
Colocalization and Interaction Study of Neuronal JNK3, JIP1, and β-Arrestin2 Together with PSD95
por: Musi, Clara Alice, et al.
Publicado: (2022) -
JNK Activation Correlates with Cognitive Impairment and Alteration of the Post-Synaptic Element in the 5xFAD AD Mouse Model
por: Priori, Erica Cecilia, et al.
Publicado: (2023) -
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
por: Bicknell, Brian, et al.
Publicado: (2023)